Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma

Conditions: Melanoma

First Posted Date: 2009-02-23

Last Posted Date: 2019-03-07

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 2000

Registration Number: NCT00849407

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream in the Treatment of Melasma

Phase 2

Conditions: Melasma

Interventions: Other: Iontophoresis
Other: Azelaic acid cream

First Posted Date: 2009-02-20

Last Posted Date: 2010-07-15

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 70

Registration Number: NCT00848458

Locations: 🇦🇹
Medical University Vienna / Depatment of Dermatology, Vienna, Austria

Fluid Intake in Kidney Failure

Not Applicable

Completed

Conditions: Chronic Renal Failure
Kidney Transplantation

Interventions: Behavioral: high fluid intake
Behavioral: normal fluid intake

First Posted Date: 2009-02-12

Last Posted Date: 2009-02-13

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 76

Registration Number: NCT00842322

Locations: 🇦🇹
Medical University Vienna, Vienna, Austria

Effects of Breastfeeding on Maternal Plasma Ghrelin and Peptide Tyrosine Tyrosine (PYY) Levels

Completed

Conditions: Breastfeeding

First Posted Date: 2009-01-29

Last Posted Date: 2011-06-01

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 20

Registration Number: NCT00831818

Locations: 🇦🇹
AKH, Medical University of Vienna, Vienna, Austria

Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients

Phase 4

Completed

Conditions: Atopic Dermatitis

Interventions: Drug: Omalizumab
Drug: Placebo

First Posted Date: 2009-01-14

Last Posted Date: 2009-01-14

Lead Sponsor: Medical University of Vienna

Registration Number: NCT00822783

Locations: 🇦🇹
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria., Vienna, Waehringer Guertel 18-20, Austria

Chronic Pain After Inguinal Hernia Repair

Phase 4

Completed

Conditions: Inguinal Hernia
Chronic Pain

Interventions: Procedure: lightweight mesh with suture fixation
Procedure: selfgrip mesh

First Posted Date: 2009-01-09

Last Posted Date: 2014-12-09

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 250

Registration Number: NCT00820131

Locations: 🇦🇹
LKH Feldkirch, Dept. of Surgery, Feldkirch, Austria
🇦🇹
KH Wiener Neustadt, Surgical Department, Wiener Neustadt, Austria
🇦🇹
LK Weinviertel Mistelbach, Surgical Department, Mistelbach, Austria

and more 4 locations

The Effect of an α2-Adrenoceptor Antagonist (Yohimbine) on Dynamic Autoregulation in the Human Middle Cerebral Artery and Ophthalmic Artery

Phase 4

Completed

Conditions: Blood Flow Velocity
Autoregulation
Ocular Physiology

First Posted Date: 2008-12-23

Last Posted Date: 2008-12-23

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 18

Registration Number: NCT00814047

Locations: 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

Does Vascular Endothelial Growth Factor (VEGF) or Complement Factor H Gene Polymorphism Play a Role in the Treatment Success With VEGF Inhibitors in Patients With Choroidal NeoVascularization (CNV)?

Not Applicable

Withdrawn

Conditions: Age-Related Macular Degeneration
Choroidal NeoVascularization

Interventions: Genetic: VEGF genotyping

First Posted Date: 2008-12-23

Last Posted Date: 2014-11-21

Lead Sponsor: Medical University of Vienna

Registration Number: NCT00813514

Locations: 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp

Phase 2

Completed

Conditions: Diabetes Mellitus, Type 1
Insulin
Retina
Regional Blood Flow

First Posted Date: 2008-12-23

Last Posted Date: 2008-12-23

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 64

Registration Number: NCT00814008

Locations: 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

Effect of Levodopa on Human Multifocal Electroretinogram

Phase 4

Completed

Conditions: Retinal Diseases

Interventions: Drug: levodopa

First Posted Date: 2008-12-22

Last Posted Date: 2008-12-22

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 20

Registration Number: NCT00812760

Locations: 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy